IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Qiming U.S. Ventures Management, LLC

Q3 2023 Holdings

Filed 2023-11-09 | 7 holdings | $75.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Icosavax IncCOM45114M109$27.2M3,510,22836.1%
Ventyx Biosciences Inc(VTYX)COM92332V107$23.8M686,37031.6%
Talaris Therapeutics IncCOM87410C104$8.2M2,932,60610.9%
Hillevax IncCOM43157M102$7.5M558,92310.0%
Jasper Therapeutics IncCOM471871103$6.0M8,519,6487.9%
Elevation Oncology IncCOM28623U101$1.6M2,370,1422.1%
Kezar Life Sciences IncCOM49372L100$986.2K828,7111.3%